Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHUKRA PHARMA   ACTAVIS
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
ACTAVIS
Dec-18
SHUKRA PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs8916,117-   
Low Rs1110,811-   
Sales per share (Unadj.) Rs53.73,953.4-  
Earnings per share (Unadj.) Rs4.0-1,273.4-  
Cash flow per share (Unadj.) Rs5.7416.6-  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.116,305.9-  
Shares outstanding (eoy) m10.96332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.93.4 27.3%   
Avg P/E ratio x12.4-10.6 -117.4%  
P/CF ratio (eoy) x8.832.3 27.1%  
Price / Book Value ratio x2.20.8 261.9%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m5474,478,069 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m440-   
Avg. sales/employee Rs Th077,804.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,060.9-  
INCOME DATA
Net Sales Rs m5881,314,899 0.0%  
Other income Rs m1225,145 0.0%   
Total revenues Rs m6001,340,044 0.0%   
Gross profit Rs m5434,457 0.2%  
Depreciation Rs m18562,091 0.0%   
Interest Rs m375,877 0.0%   
Profit before tax Rs m44-578,366 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,507 0.0%   
Tax Rs m0-7,330 -0.0%   
Profit after tax Rs m44-423,530 -0.0%  
Gross profit margin %9.12.6 347.9%  
Effective tax rate %0.81.3 62.5%   
Net profit margin %7.5-32.2 -23.3%  
BALANCE SHEET DATA
Current assets Rs m531539,303 0.1%   
Current liabilities Rs m425477,085 0.1%   
Net working cap to sales %18.04.7 379.5%  
Current ratio x1.21.1 110.5%  
Inventory Days Days020 0.0%  
Debtors Days Days1,87366 2,824.3%  
Net fixed assets Rs m219148,839 0.1%   
Share capital Rs m390-   
"Free" reserves Rs m2140-   
Net worth Rs m2535,423,345 0.0%   
Long term debt Rs m381,909,756 0.0%   
Total assets Rs m7508,477,923 0.0%  
Interest coverage x16.8-6.6 -253.8%   
Debt to equity ratio x0.10.4 42.3%  
Sales to assets ratio x0.80.2 506.0%   
Return on assets %6.3-4.1 -152.5%  
Return on equity %17.4-7.8 -223.1%  
Return on capital %16.2-4.8 -335.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m32469,764 0.0%  
From Investments Rs m-44258,074 -0.0%  
From Financial Activity Rs m49-806,256 -0.0%  
Net Cashflow Rs m37-78,026 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.29 Rs / USD

Compare SHUKRA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SHUKRA PHARMA With: GUJ.INJ(KER)  BIOCON   ZENITH DRUGS LTD.  CORAL LAB.  JUBILANT PHARMOVA   



Today's Market

Sensex Today Ends 114 Points Higher | Metal Stocks Shine | VI Tanks 9% Sensex Today Ends 114 Points Higher | Metal Stocks Shine | VI Tanks 9%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.